ID   MBOA5_RAT               Reviewed;         487 AA.
AC   Q5FVN0;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   24-JUL-2024, entry version 122.
DE   RecName: Full=Lysophospholipid acyltransferase 5;
DE            Short=LPLAT 5;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q6P1A2};
DE   AltName: Full=1-acylglycerophosphocholine O-acyltransferase;
DE            EC=2.3.1.23 {ECO:0000250|UniProtKB:Q6P1A2};
DE   AltName: Full=1-acylglycerophosphoethanolamine O-acyltransferase;
DE            EC=2.3.1.n7 {ECO:0000250|UniProtKB:Q6P1A2};
DE   AltName: Full=1-acylglycerophosphoserine O-acyltransferase;
DE            EC=2.3.1.n6 {ECO:0000250|UniProtKB:Q6P1A2};
DE   AltName: Full=Lysophosphatidylcholine acyltransferase 3;
DE            Short=Lyso-PC acyltransferase 3;
DE   AltName: Full=Membrane-bound O-acyltransferase domain-containing protein 5;
DE            Short=O-acyltransferase domain-containing protein 5;
GN   Name=Lpcat3; Synonyms=Grcc3f {ECO:0000312|EMBL:AAH89869.1}, Mboat5, Oact5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Lysophospholipid O-acyltransferase (LPLAT) that catalyzes the
CC       reacylation step of the phospholipid remodeling process also known as
CC       the Lands cycle. Catalyzes transfer of the fatty acyl chain from fatty
CC       acyl-CoA to 1-acyl lysophospholipid to form various classes of
CC       phospholipids. Converts 1-acyl lysophosphatidylcholine (LPC) into
CC       phosphatidylcholine (PC) (LPCAT activity), 1-acyl
CC       lysophosphatidylserine (LPS) into phosphatidylserine (PS) (LPSAT
CC       activity) and 1-acyl lysophosphatidylethanolamine (LPE) into
CC       phosphatidylethanolamine (PE) (LPEAT activity). Favors polyunsaturated
CC       fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs
CC       (By similarity). Has higher activity for LPC acyl acceptors compared to
CC       LPEs and LPSs. Can also transfer the fatty acyl chain from fatty acyl-
CC       CoA to 1-O-alkyl lysophospholipid or 1-O-alkenyl lysophospholipid with
CC       lower efficiency. Acts as a major LPC O-acyltransferase in liver and
CC       intestine. As a component of the liver X receptor/NR1H3 or NR1H2
CC       signaling pathway, mainly catalyzes the incorporation of arachidonate
CC       into PCs of endoplasmic reticulum (ER) membranes, increasing membrane
CC       dynamics and enabling triacylglycerols transfer to nascent very low-
CC       density lipoprotein (VLDL) particles. Promotes processing of sterol
CC       regulatory protein SREBF1 in hepatocytes, likely by facilitating the
CC       translocation of SREBF1-SCAP complex from ER to the Golgi apparatus.
CC       Participates in mechanisms by which the liver X receptor/NR1H3 or NR1H2
CC       signaling pathway counteracts lipid-induced ER stress response and
CC       inflammation. Down-regulates hepatic inflammation by limiting
CC       arachidonic acid availability for synthesis of inflammatory
CC       eicosanoids, such as prostaglandins. In enterocytes, acts as a
CC       component of a gut-brain feedback loop that coordinates dietary lipid
CC       absorption and food intake. Regulates the abundance of PCs containing
CC       linoleate and arachidonate in enterocyte membranes, enabling passive
CC       diffusion of fatty acids and cholesterol across the membrane for
CC       efficient chylomicron assembly. In the intestinal crypt, acts as a
CC       component of dietary-responsive phospholipid-cholesterol axis,
CC       regulating the biosynthesis of cholesterol and its mitogenic effects on
CC       intestinal stem cells (By similarity). {ECO:0000250|UniProtKB:Q6P1A2,
CC       ECO:0000250|UniProtKB:Q91V01}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + an acyl-CoA = a 1,2-
CC         diacyl-sn-glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:12937,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:58342; EC=2.3.1.23;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12938;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine + an acyl-CoA = a
CC         1,2-diacyl-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:32995, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:64612; EC=2.3.1.n7;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32996;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-L-serine + an acyl-CoA = a 1,2-
CC         diacyl-sn-glycero-3-phospho-L-serine + CoA; Xref=Rhea:RHEA:33191,
CC         ChEBI:CHEBI:57262, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:64379; EC=2.3.1.n6;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33192;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phosphocholine = 1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37563, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:58168, ChEBI:CHEBI:60000;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37564;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phosphocholine = 1-acyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:37559,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:75063; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37560;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + dodecanoyl-CoA =
CC         1-hexadecanoyl-2-dodecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37515, ChEBI:CHEBI:57287, ChEBI:CHEBI:57375,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:75018;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37516;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + octadecanoyl-CoA
CC         = 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:35987, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:73000;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35988;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-dodecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA =
CC         1-dodecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37511, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:74966, ChEBI:CHEBI:75017;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37512;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-tetradecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA
CC         = 1-tetradecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37655, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:64489, ChEBI:CHEBI:75062;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37656;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA
CC         = 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:35983, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35984;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA
CC         = 1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37527, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:73858, ChEBI:CHEBI:75026;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37528;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine +
CC         hexadecanoyl-CoA = 1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37383, ChEBI:CHEBI:28610,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74667;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37384;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:37207, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:61540, ChEBI:CHEBI:72998, ChEBI:CHEBI:74000;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37208;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine + CoA; Xref=Rhea:RHEA:35991, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:72998, ChEBI:CHEBI:73001;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35992;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine = 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:35995,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73002; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35996;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-dodecanoyl-sn-
CC         glycero-3-phosphocholine = 1-dodecanoyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37483, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:74966, ChEBI:CHEBI:74967;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37484;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-hexadecanoyl-sn-
CC         glycero-3-phosphocholine = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:35999, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:73003;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36000;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-octadecanoyl-sn-
CC         glycero-3-phosphocholine = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37479, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:73858, ChEBI:CHEBI:74965;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37480;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-eicosanoyl-sn-
CC         glycero-3-phosphocholine = 1-eicosanoyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37487, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:74968, ChEBI:CHEBI:74970;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37488;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphocholine = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + CoA; Xref=Rhea:RHEA:37387, ChEBI:CHEBI:28610, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:74669;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37388;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-
CC         3-phosphocholine = 1-(9Z)-octadecenoyl-2-(9Z,12Z)-octadecadienoyl-sn-
CC         glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:37391,
CC         ChEBI:CHEBI:28610, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:74670; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37392;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn-
CC         glycero-3-phosphocholine = 1-(9Z)-octadecenoyl-2-(5Z,8Z,11Z,14Z)-
CC         icosatetraenoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:37395, ChEBI:CHEBI:28610, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57368, ChEBI:CHEBI:74671;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37396;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phosphoethanolamine = 1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-
CC         phosphoethanolamine + CoA; Xref=Rhea:RHEA:37579, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:64381, ChEBI:CHEBI:75069;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37580;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-
CC         3-phosphoethanolamine = 1-(9Z)-octadecenoyl-2-(9Z,12Z)-
CC         octadecadienoyl-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:37503, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:74971, ChEBI:CHEBI:74977;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37504;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-(10Z-heptadecenoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-(10Z-heptadecenoyl)-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:64228, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:149768, ChEBI:CHEBI:149770;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64229;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phosphoethanolamine = 1-acyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphoethanolamine + CoA; Xref=Rhea:RHEA:37575,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:64381,
CC         ChEBI:CHEBI:75067; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37576;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-hexadecanoyl-sn-
CC         glycero-3-phosphoethanolamine = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:36023, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36024;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-(9Z)-octadecenoyl-2-
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphoethanolamine +
CC         CoA; Xref=Rhea:RHEA:37495, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:74971, ChEBI:CHEBI:74975;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37496;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(10Z-heptadecenoyl)-
CC         sn-glycero-3-phosphoethanolamine = 1-(10Z-heptadecenoyl)-2-
CC         (5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine +
CC         CoA; Xref=Rhea:RHEA:64204, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:149768, ChEBI:CHEBI:149769;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64205;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-O-(1Z-alkenyl)-sn-
CC         glycero-3-phosphoethanolamine = 1-O-(1Z)-alkenyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phosphoethanolamine + CoA;
CC         Xref=Rhea:RHEA:37635, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:77288, ChEBI:CHEBI:77295;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37636;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + a 1-acyl-sn-glycero-3-phospho-
CC         L-serine = 1-acyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-L-
CC         serine + CoA; Xref=Rhea:RHEA:37567, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:64379, ChEBI:CHEBI:75066;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37568;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + a 1-acyl-sn-glycero-3-
CC         phospho-L-serine = 1-acyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycero-3-phospho-L-serine + CoA; Xref=Rhea:RHEA:37571,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:64379,
CC         ChEBI:CHEBI:75065; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37572;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phospho-L-
CC         serine = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-
CC         serine + CoA; Xref=Rhea:RHEA:37531, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:75020, ChEBI:CHEBI:75029;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37532;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-L-serine = 1,2-di-(9Z)-octadecenoyl-sn-glycero-3-phospho-L-
CC         serine + CoA; Xref=Rhea:RHEA:37407, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:74617, ChEBI:CHEBI:74905;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37408;
CC         Evidence={ECO:0000250|UniProtKB:Q91V01};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phospho-L-serine = 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-
CC         glycero-3-phospho-L-serine + CoA; Xref=Rhea:RHEA:37535,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:75020,
CC         ChEBI:CHEBI:75031; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37536;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-
CC         3-phospho-L-serine = 1-(9Z-octadecenoyl)-2-(9Z,12Z-octadienoyl)-sn-
CC         glycero-3-phospho-L-serine + CoA; Xref=Rhea:RHEA:37375,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:74617,
CC         ChEBI:CHEBI:74892; Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37376;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-hexadecanoyl-sn-
CC         glycero-3-phospho-L-serine = 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-phospho-L-serine + CoA;
CC         Xref=Rhea:RHEA:37539, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:75020, ChEBI:CHEBI:75032;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37540;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn-
CC         glycero-3-phospho-L-serine = 1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-sn-glycero-3-phospho-L-serine + CoA;
CC         Xref=Rhea:RHEA:37379, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:74617, ChEBI:CHEBI:74897;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37380;
CC         Evidence={ECO:0000250|UniProtKB:Q6P1A2};
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000250|UniProtKB:Q6P1A2}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q6P1A2}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- DOMAIN: The di-lysine motif confers endoplasmic reticulum localization.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the membrane-bound acyltransferase family.
CC       {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC089869; AAH89869.1; -; mRNA.
DR   RefSeq; NP_001012189.1; NM_001012189.1.
DR   RefSeq; XP_017448194.1; XM_017592705.1.
DR   AlphaFoldDB; Q5FVN0; -.
DR   SMR; Q5FVN0; -.
DR   STRING; 10116.ENSRNOP00000017090; -.
DR   GlyCosmos; Q5FVN0; 1 site, No reported glycans.
DR   GlyGen; Q5FVN0; 1 site.
DR   iPTMnet; Q5FVN0; -.
DR   PhosphoSitePlus; Q5FVN0; -.
DR   jPOST; Q5FVN0; -.
DR   PaxDb; 10116-ENSRNOP00000017090; -.
DR   Ensembl; ENSRNOT00000017090.6; ENSRNOP00000017090.4; ENSRNOG00000012269.6.
DR   Ensembl; ENSRNOT00055017051; ENSRNOP00055013710; ENSRNOG00055010100.
DR   Ensembl; ENSRNOT00060056123; ENSRNOP00060046369; ENSRNOG00060032395.
DR   Ensembl; ENSRNOT00065049928; ENSRNOP00065041009; ENSRNOG00065028897.
DR   GeneID; 362434; -.
DR   KEGG; rno:362434; -.
DR   UCSC; RGD:1310223; rat.
DR   AGR; RGD:1310223; -.
DR   CTD; 10162; -.
DR   RGD; 1310223; Lpcat3.
DR   eggNOG; KOG2705; Eukaryota.
DR   GeneTree; ENSGT01030000234564; -.
DR   HOGENOM; CLU_011340_6_1_1; -.
DR   InParanoid; Q5FVN0; -.
DR   OMA; NAWVSRY; -.
DR   OrthoDB; 5297955at2759; -.
DR   PhylomeDB; Q5FVN0; -.
DR   TreeFam; TF106143; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   UniPathway; UPA00085; -.
DR   PRO; PR:Q5FVN0; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000012269; Expressed in ovary and 19 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0106262; F:1-acylglycerophosphoethanolamine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0106263; F:1-acylglycerophosphoserine O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0071617; F:lysophospholipid acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0034378; P:chylomicron assembly; ISS:UniProtKB.
DR   GO; GO:0090158; P:endoplasmic reticulum membrane organization; ISS:UniProtKB.
DR   GO; GO:0036335; P:intestinal stem cell homeostasis; ISS:UniProtKB.
DR   GO; GO:0030258; P:lipid modification; IBA:GO_Central.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:1903573; P:negative regulation of response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0045797; P:positive regulation of intestinal cholesterol absorption; ISS:UniProtKB.
DR   GO; GO:1905885; P:positive regulation of triglyceride transport; ISS:UniProtKB.
DR   GO; GO:0045540; P:regulation of cholesterol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0097006; P:regulation of plasma lipoprotein particle levels; ISO:RGD.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; ISS:UniProtKB.
DR   InterPro; IPR049941; LPLAT_7/PORCN-like.
DR   InterPro; IPR004299; MBOAT_fam.
DR   PANTHER; PTHR13906:SF14; LYSOPHOSPHOLIPID ACYLTRANSFERASE 5; 1.
DR   PANTHER; PTHR13906; PORCUPINE; 1.
DR   Pfam; PF03062; MBOAT; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Acyltransferase; Endoplasmic reticulum; Glycoprotein;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P1A2"
FT   CHAIN           2..487
FT                   /note="Lysophospholipid acyltransferase 5"
FT                   /id="PRO_0000233384"
FT   TRANSMEM        44..64
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        67..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        111..131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        178..198
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        285..305
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        364..384
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        422..442
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        453..473
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           484..487
FT                   /note="Di-lysine motif"
FT   ACT_SITE        338
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        374
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P1A2"
FT   CARBOHYD        308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   487 AA;  56018 MW;  29F44D92190957A2 CRC64;
     MASTADGDVG ETLGQMRGLW PGVEDLSLNK LATSLGASEQ ALRLIFSIFL GYPLALFYRH
     YLFYKDSYLI HLFHAFSGLS IAYFNFGHQF YHSLLCVVLQ FLILRLMGRT ITAVFTTLCF
     QMAYLLAGYY YTATGDYDIK WTMPHCVLTL KLIGLSIDYY DGGKDRNSLS SEQQKYAILG
     VPSLLEVAGF SYFYGAFLVG PQFSMNHYMK LVKGQLTDVP GKMPNSTIPA LKRLSLGLVY
     LVGYTLLSPH ITEDYLLTED YDTRPFWFRC MYMLIWGKFV LYKYVTCWLV TEGVCILSGL
     GFNGFEENGT VKWDACANMK VWLFETTPRF TGTIASFNIN TNAWVARYIF KRLKFLGNKE
     LSQGLSLLFL ALWHGLHSGY LICFQMEFLI VIVEKQATNL IRDSPALSSL ASITALQPFY
     YLVQQTIHWL FMGYSMTAFC LFTWDKWLKV YRSIYFLGHV FFLSLLFTLP YVYKAMVPRK
     EKLKKRE
//
